OPERA LTD-ADR (OPRA)

US68373M1071 - ADR

18.88  -0.06 (-0.32%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to OPRA. OPRA was compared to 280 industry peers in the Software industry. OPRA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. OPRA has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make OPRA suitable for value and growth and quality investing!



7

1. Profitability

1.1 Basic Checks

OPRA had positive earnings in the past year.
OPRA had a positive operating cash flow in the past year.
OPRA had positive earnings in 4 of the past 5 years.
Of the past 5 years OPRA 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 15.75%, OPRA belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
The Return On Equity of OPRA (17.50%) is better than 85.35% of its industry peers.
OPRA has a better Return On Invested Capital (7.35%) than 80.59% of its industry peers.
Industry RankSector Rank
ROA 15.75%
ROE 17.5%
ROIC 7.35%
ROA(3y)4.23%
ROA(5y)6.86%
ROE(3y)4.67%
ROE(5y)7.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OPRA has a better Profit Margin (35.41%) than 95.60% of its industry peers.
OPRA's Profit Margin has improved in the last couple of years.
The Operating Margin of OPRA (18.90%) is better than 85.35% of its industry peers.
OPRA's Operating Margin has declined in the last couple of years.
OPRA has a better Gross Margin (74.85%) than 65.20% of its industry peers.
OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.9%
PM (TTM) 35.41%
GM 74.85%
OM growth 3Y167.01%
OM growth 5Y-10.09%
PM growth 3Y-27.56%
PM growth 5Y12.06%
GM growth 3Y-7.05%
GM growth 5Y-4.77%

8

2. Health

2.1 Basic Checks

OPRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OPRA has less shares outstanding than it did 1 year ago.
OPRA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for OPRA is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 11.50 indicates that OPRA is not in any danger for bankruptcy at the moment.
OPRA's Altman-Z score of 11.50 is amongst the best of the industry. OPRA outperforms 84.98% of its industry peers.
OPRA has a debt to FCF ratio of 0.11. This is a very positive value and a sign of high solvency as it would only need 0.11 years to pay back of all of its debts.
OPRA has a better Debt to FCF ratio (0.11) than 79.12% of its industry peers.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.01, OPRA is doing good in the industry, outperforming 62.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.11
Altman-Z 11.5
ROIC/WACC0.89
WACC8.28%

2.3 Liquidity

A Current Ratio of 2.10 indicates that OPRA has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.10, OPRA is doing good in the industry, outperforming 61.54% of the companies in the same industry.
OPRA has a Quick Ratio of 2.10. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
OPRA has a better Quick ratio (2.10) than 63.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 165.00% over the past year.
Measured over the past years, OPRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 39.43% on average per year.
OPRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.45%.
The Revenue has been growing by 19.77% on average over the past years. This is quite good.
EPS 1Y (TTM)165%
EPS 3Y68.46%
EPS 5Y39.43%
EPS Q2Q%44.44%
Revenue 1Y (TTM)18.45%
Revenue growth 3Y31.05%
Revenue growth 5Y19.77%
Sales Q2Q%20.04%

3.2 Future

The Earnings Per Share is expected to grow by 12.87% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.43% on average over the next years. This is quite good.
EPS Next Y-50.35%
EPS Next 2Y-22.26%
EPS Next 3Y-9.88%
EPS Next 5Y12.87%
Revenue Next Year19.26%
Revenue Next 2Y17.37%
Revenue Next 3Y16.66%
Revenue Next 5Y15.43%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.91 indicates a reasonable valuation of OPRA.
Based on the Price/Earnings ratio, OPRA is valued cheaply inside the industry as 94.87% of the companies are valued more expensively.
OPRA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.17.
OPRA is valuated correctly with a Price/Forward Earnings ratio of 15.94.
Based on the Price/Forward Earnings ratio, OPRA is valued cheaply inside the industry as 83.88% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.59. OPRA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 8.91
Fwd PE 15.94

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OPRA is valued cheaply inside the industry as 86.08% of the companies are valued more expensively.
86.81% of the companies in the same industry are more expensive than OPRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.78
EV/EBITDA 15.84

4.3 Compensation for Growth

OPRA has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as OPRA's earnings are expected to decrease with -9.88% in the coming years.
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2Y-22.26%
EPS Next 3Y-9.88%

5

5. Dividend

5.1 Amount

OPRA has a Yearly Dividend Yield of 4.04%, which is a nice return.
Compared to an average industry Dividend Yield of 13.69, OPRA pays a better dividend. On top of this OPRA pays more dividend than 97.80% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, OPRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

OPRA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

23.47% of the earnings are spent on dividend by OPRA. This is a low number and sustainable payout ratio.
DP23.47%
EPS Next 2Y-22.26%
EPS Next 3Y-9.88%

OPERA LTD-ADR

NASDAQ:OPRA (1/2/2025, 1:55:04 PM)

18.88

-0.06 (-0.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)N/A N/A
Inst Owners9.93%
Inst Owner Change8.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.67B
Analysts83.33
Price Target24.65 (30.56%)
Short Float %1.88%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Dividend Growth(5Y)N/A
DP23.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.27%
Min EPS beat(2)1.96%
Max EPS beat(2)4.58%
EPS beat(4)3
Avg EPS beat(4)119.79%
Min EPS beat(4)-23.97%
Max EPS beat(4)496.58%
EPS beat(8)6
Avg EPS beat(8)72%
EPS beat(12)6
Avg EPS beat(12)-79.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.89%
Max Revenue beat(2)0.3%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.3%
Revenue beat(8)5
Avg Revenue beat(8)0.66%
Revenue beat(12)9
Avg Revenue beat(12)1.62%
Revenue beat(16)13
Avg Revenue beat(16)3.14%
PT rev (1m)0%
PT rev (3m)10.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE 8.91
Fwd PE 15.94
P/S 3.71
P/FCF 19.78
P/OCF 15.38
P/B 1.83
P/tB 4.35
EV/EBITDA 15.84
EPS(TTM)2.12
EY11.23%
EPS(NY)1.18
Fwd EY6.27%
FCF(TTM)0.95
FCFY5.06%
OCF(TTM)1.23
OCFY6.5%
SpS5.09
BVpS10.3
TBVpS4.34
PEG (NY)N/A
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 15.75%
ROE 17.5%
ROCE 9.25%
ROIC 7.35%
ROICexc 8.31%
ROICexgc 23.59%
OM 18.9%
PM (TTM) 35.41%
GM 74.85%
FCFM 18.75%
ROA(3y)4.23%
ROA(5y)6.86%
ROE(3y)4.67%
ROE(5y)7.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y279.89%
ROICexcg growth 5Y-18.67%
ROICexc growth 3Y262.56%
ROICexc growth 5Y1.19%
OM growth 3Y167.01%
OM growth 5Y-10.09%
PM growth 3Y-27.56%
PM growth 5Y12.06%
GM growth 3Y-7.05%
GM growth 5Y-4.77%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.11
Debt/EBITDA 0.05
Cap/Depr 166.5%
Cap/Sales 5.36%
Interest Coverage 152.62
Cash Conversion 108.97%
Profit Quality 52.94%
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 11.5
F-Score5
WACC8.28%
ROIC/WACC0.89
Cap/Depr(3y)14.81%
Cap/Depr(5y)22.93%
Cap/Sales(3y)0.64%
Cap/Sales(5y)1.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)165%
EPS 3Y68.46%
EPS 5Y39.43%
EPS Q2Q%44.44%
EPS Next Y-50.35%
EPS Next 2Y-22.26%
EPS Next 3Y-9.88%
EPS Next 5Y12.87%
Revenue 1Y (TTM)18.45%
Revenue growth 3Y31.05%
Revenue growth 5Y19.77%
Sales Q2Q%20.04%
Revenue Next Year19.26%
Revenue Next 2Y17.37%
Revenue Next 3Y16.66%
Revenue Next 5Y15.43%
EBIT growth 1Y44.58%
EBIT growth 3Y249.92%
EBIT growth 5Y7.68%
EBIT Next Year100.76%
EBIT Next 3Y41.59%
EBIT Next 5Y30.59%
FCF growth 1Y80.86%
FCF growth 3Y-3.07%
FCF growth 5Y20.91%
OCF growth 1Y118.94%
OCF growth 3Y-3.92%
OCF growth 5Y19.59%